EFFECT OF OMACOR ON THE MORPHOLOGICAL STATUS OF VENOUS BYPASSES IN PATIENTS WITH CORONARY HEART DISEASE AFTER MYOCARDIAL REVASCULARIZATION
- Authors: Panov A.V.1, Mitrofanova L.B.1, Kozulin V.Y.1, Usova E.A.1, Alugishvili M.Z.1, Tyan N.A.1, Panov -1, Mitrofanova L1, Kozulin V1, Usova V1, Alugivishvili M1, Tyan N1
-
Affiliations:
- Issue: No 5 (2011)
- Pages: 111-115
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278837
- ID: 278837
Cite item
Full Text
Abstract
About the authors
Aleksey Vladimirovich Panov
Lyubov' Borisovna Mitrofanova
Vikentiy Yur'evich Kozulin
Elena Anatol'evna Usova
Marianna Zakhar'evna Alugishvili
Natal'ya Afanas'evna Tyan
- Panov
L Mitrofanova
V Kozulin
V Usova
M Alugivishvili
N Tyan
References
- Беленков Ю.Н., Акчурин Р.С., Савченко А.П. Рентгеноморфологическая характеристика поражения шунтов у больных ишемической болезнью сердца после операции аортокоронарного шунтирования // Кардиология 2000. № 1. С. 6-12.
- Ардашев А.В., Коков Л.С., Синицын В.Е. Обследование и рентгенохирургическое лечение больных после операции аортокоонарного шунтирования. Медпрактика-М., 2007.
- Fitzgibbon GM, Kafka HP, Leach AJ. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years. J Am Coll Cardiol 1996;28:616-26.
- Motwani JG, Topol EJ. Aortocoronary Saphenous Vein Graft Disease: Pathogenesis, Predisposition, and Prevention. Circulation 1998;97:916-31.
- Hassantash SA, Bikdeli B, Kalantarian S, et al. Pathophysiology of Aortocoronary Saphenous Vein Bypass Graft Disease Asian Cardiovasc Thorac Ann 2008;16:331-36.
- Donald S. Baim Percutaneous Treatment of Saphenous Vein Graft Disease. The ongoing challenge JACC 2003;42(8):1370-2.
- Bang H, Dyerberg J, et al. The composition of the Eskimo food in Northwestern Greenland. Am J Clin Nutr 1980;33:2657-66.
- Marchioli R, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the GISSI-Prevenzione. Circulation 2002;105:1897-1903.
- Calo L, Bianconi L, Collivicchi F, et al. Рrevention of atrial fibrillation by n-3 polyunsaturated fatty acids after coronary artery bypass grafting. J Am Coll Cardiol 2005;45:1723-28.
- Harris W, Reid K, Sands S, et al. Red blood cell omega-3 fatty acids in acute coronary syndrome patients. Circulation 2007;115(8):267.
- Guidelines on myocardial revascularization The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Available at www.escardio.org/guidelines
- Панов А.В., Гордеев М.Л., Нильк Р.Я. и др. Применение омакора для предупреждения фибрилляции предсердий после хирургической реваскуляризации миокарда (Исследование АКСИОМА) // Артериальная гипертензия 2008. № 14. C. 162-64.
- Baggiolini M. Chemokines and leukocyte traffic. Nature 1998;392:565-68.
- Balashov KE, Rottman JB, Weiner HL, et al. CCR5 and CXCR3 T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci USA 1999;96:6873-78.
- Balasingam V, Tejada-Berges T, Wright E, et al. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci 1994;14:846-56.
- Balding CE, Howie AJ, Drake-Lee AB, et al. Th2 dominance in nasal mucosa in patients with Wegener's granulomatosis. Clin Exp Immunol 2001;125:332-39.
Supplementary files
![](/img/style/loading.gif)